Related Experiment Videos
Summary
Photochemotherapy using 8-methoxypsoralen and UVA light (PUVA) effectively treats severe alopecia areata, with 73% of patients showing good to excellent results. Factors like disease pattern and age of onset influence treatment success, and recurrences are infrequent.
Area of Science:
- Dermatology
- Photomedicine
Background:
- Alopecia areata is an autoimmune condition causing hair loss.
- Severe cases often present treatment challenges.
Purpose of the Study:
- To evaluate the efficacy of 8-methoxypsoralen and UVA (PUVA) therapy for severe alopecia areata.
- To identify factors influencing treatment outcomes.
Main Methods:
- 41 patients with severe alopecia areata received either local or oral 8-methoxypsoralen with UVA irradiation.
- Treatment response and recurrence rates were monitored.
Main Results:
- A good to excellent response was achieved in 73% of patients (26 out of 41).
- Favorable outcomes were observed in patients with circumscribed or ophiasic alopecia, and those over 20 years old at disease onset.
- Atopy or family history did not impact treatment success.
Conclusions:
- PUVA therapy is an effective treatment for severe alopecia areata.
- Disease pattern and age of onset are significant prognostic factors.
- Long-term follow-up showed a low recurrence rate.